FDA issues first approval for a diabetes medicine that slows progression of CKD

Author: AKF Staff  |  Posted:

For individuals living with diabetes—the leading cause of kidney failure—the approval by the U.S. Food and Drug Administration of the diabetes medicine canagliflozin (brand name INVOKANA®) to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure patients with type 2 diabetes and diabetic kidney disease is cause for optimism. READ MORE >>

TOPICS: News, Research, Kidney disease prevention

First living HIV-positive living kidney donor paves the way for more people to access transplants

Author: Nina Martinez  |  Posted:

Nina Martinez made history in March as the first person with HIV to become a living kidney donor. She told AKF that the decision to donate her kidney was “a long time coming.” While she has been called a hero in stories about the transplant, she feels “it’s not heroic to help someone who needs help”—it is just the right thing to do. READ MORE >>

TOPICS: Kidney transplant, Kidney failure
Items 1 - 12 of 153  12345678910Next

Connect with Us